SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-016824
Filing Date
2021-05-11
Accepted
2021-05-11 16:30:38
Documents
14
Period of Report
2021-05-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024426_8k.htm   iXBRL 8-K 49883
2 EXHIBIT 99.1 brhc10024426_ex99-1.htm EX-99.1 13295
6 image00001.jpg GRAPHIC 2549
  Complete submission text file 0001140361-21-016824.txt   213799

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alxn-20210511.xsd EX-101.SCH 3920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20210511_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20210511_pre.xml EX-101.PRE 16040
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10024426_8k_htm.xml XML 4070
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 21911734
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences